healio.com

57 articles in the TruthFoundry index. Each links out to the original.

• Retatrutide reduces osteoarthritis pain and weight in obese trial patients · Phase 3 trial finds retatrutide lowers knee pain and body weight in obese adults.
• Methylene blue therapy shows promise for diabetic foot ulcer healing · Published review finds methylene blue light therapy may aid chronic diabetic wound healing.
• Inflammation links cardiology, dermatology, rheumatology clinical practice · Medical speaker outlines cardiovascular risk from autoimmune inflammation across specialties.
• Early thyroid cancer linked to higher future malignancy risk in young patients · Study finds young differentiated thyroid cancer survivors face elevated second cancer risk.
• Burosumab-twza outperforms standard therapy for adult X-linked hypophosphatemia · Real-world study finds burosumab-twza improves phosphate levels and patient outcomes over conventional therapy.
• Taltz Zepbound combo cuts 10-year heart disease risk by 30% for psoriatic patients · Combined Taltz and Zepbound therapy reduces predicted 10-year cardiovascular risk by 30%
• EC-104 DME implant Phase 2 trial meets primary safety endpoint · Eclipse Life Sciences announces EC-104 Phase 2 trial met primary safety endpoint for DME.
• US pediatric endocrinology shortage driven by low pay and limited exposure · United States pediatric endocrinologist shortage creates care gaps for children with diabetes.
• Study finds 2025 ATA thyroglobulin cutoff fails higher-risk thyroid cancer patients · University of Washington research finds thyroglobulin alone cannot confirm remission for higher-risk thyroid cancer.
• New technologies and therapies show bright future for type 1 diabetes care · Researcher outlines three advancing areas transforming type 1 diabetes treatment.
• Review Links PCOS/PMOS to Higher Alzheimer's Disease Risk · A review suggests women with PCOS/PMOS may face elevated Alzheimer's disease risk, potentially mediated by metabolic disorders.
• Texas Gastroenterology Practice Integrates DEI into Clinician Recruitment · Austin Gastroenterology seeks clinicians committed to community care alongside clinical excellence.
• AMA Opposes FAA Plan to Eliminate Federal Standards for Airline Medical Kits · The American Medical Association opposes a proposed FAA rule that would remove federal minimum standards for in-flight emergency medical kits.
• FDA Clears Needle-Free CGM for Over-the-Counter Sale · FDA grants 510(k) clearance for Biolinq Shine, a needle-free continuous glucose monitor for adults over 22.
• GLP-1 Drug Use Linked to Higher Rates of Nail Detachment and Hair Loss · A new study finds GLP-1 receptor agonist users have significantly higher rates of nail disorders and hair loss compared to controls.
• Survodutide Shows Impressive Weight Loss in Type 2 Diabetes Patients · New trial data shows survodutide induced up to 13.1% weight loss in adults with type 2 diabetes and obesity.
• Study finds high physical activity linked to reduced psoriasis severity · Published medical research associates higher physical activity with lower psoriasis severity.
• GLP-1 success requires patient-centered nutrition and lifestyle support, specialists urge · Diabetes care specialists at ADCES26 urged pairing GLP-1 medications with high-protein diets and exercise for sustainable long-term success.
• ASN Issues New CKM Syndrome Guidance for Nephrologists · The American Society of Nephrology released tailored guidance for nephrologists to manage cardiovascular-kidney-metabolic syndrome.
• Novo Nordisk Reports CagriSema Outperforms Tirzepatide in Weight Loss Trials · Novo Nordisk announces CagriSema achieved greater weight loss than tirzepatide in two recent clinical trials.
• US Senate holds first ever congressional hearing on menopause care · US Senate Aging Committee conducted the first congressional hearing on menopause care gaps.
• Endocrine Society issues scientific statement urging obesity research beyond weight loss, launches Center on Obesity · Endocrine Society publishes scientific statement calling for research on obesity outcomes beyond weight loss and launches Center on Obesity.
• Diabetes Specialist Explains Variations in Automated Insulin Delivery Algorithms · Erin Henry explains how different automated insulin delivery algorithms require distinct management strategies for patients.
• Pelacarsen fails to reduce cardiovascular events; expert urges continued Lp(a) trials · The HORIZON trial of Lp(a)-lowering drug pelacarsen failed to reduce cardiovascular events, according to an editorial by Deepak L. Bhatt.
• Endocrinologist Thanh Hoang argues endocrinologists should anchor thyroid eye disease care · Thanh D. Hoang argues new treatments justify endocrinologists taking the lead in thyroid eye disease care.
• New Study Finds Menopause Data Inconsistent in Electronic Health Records · A systematic review reveals menopause status and symptoms are often missing or inconsistently documented in electronic health records.
• New Dual Sensor Aims to Improve Ketone Monitoring in Diabetes Care · FDA-approved dual glucose and ketone sensors offer new tools for managing diabetes and preventing diabetic ketoacidosis.
• Digital health tools and local clinic data sharing can improve posttransplant care, experts say · Thermo Fisher executives Richard Knight and Tina Liedtky say digital health tools and EMR integration with local clinics could improve posttransplant care.
• Diabetes educators urged to use social media to build trust and share credible information · Two diabetes educators say specialists should use social media to share credible information and build trust with patients.
• Oncologist outlines AI bias and integrity barriers in healthcare · Oncologist Chadi Nabhan addresses AI risks for safe clinical healthcare use.